Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-09-01

FDA Approved: ADAPALENE — Supplemental Application (Mayne Pharma Commercial LLC.)

View source ↗

Summary

FDA approved a supplemental application for adapalene submitted by Mayne Pharma Commercial LLC., resulting in an approved update to the product's labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Adapalene (Adapalene)

Snippet

SUPPL AP for ADAPALENE (ADAPALENE)